KLF11是Kruppel样转录因子家族中的成员,在胰腺、肌肉、肝脏等多种组织中广泛表达,参与调控细胞增殖、糖脂代谢等多种重要的生理及病理过程。研究表明,KLF11在胰腺癌、肺癌等多种肿瘤中的表达量明显下降,其抑癌作用亦明显降低,这种异常...KLF11是Kruppel样转录因子家族中的成员,在胰腺、肌肉、肝脏等多种组织中广泛表达,参与调控细胞增殖、糖脂代谢等多种重要的生理及病理过程。研究表明,KLF11在胰腺癌、肺癌等多种肿瘤中的表达量明显下降,其抑癌作用亦明显降低,这种异常表达参与了肿瘤的发生发展过程。人群及动物模型研究发现,KLF11能够调控胰岛素基因的表达,与青少年发病型成年糖尿病(maturity onset diabetes in young,MODY)密切相关。此外,KLF11还调控脂质氧化与转运,并参与白色脂肪的棕色化过程。本文就其生物学功能研究进展作一综述。展开更多
BACKGROUND Maturity-onset diabetes of the young(MODY)is the most common monogenic type of diabetes.Recently,14 gene mutations have been found to be associated with MODY.In addition,the KLF11 gene mutation is the patho...BACKGROUND Maturity-onset diabetes of the young(MODY)is the most common monogenic type of diabetes.Recently,14 gene mutations have been found to be associated with MODY.In addition,the KLF11 gene mutation is the pathogenic gene of MODY7.To date,the clinical and functional characteristics of the novel KLF11mutation c.G31A have not yet been reported.CASE SUMMARY We report of a 30-year-old male patient with a one-year history of nonketosisprone diabetes and a 3-generation family history of diabetes.The patient was found to carry a KLF11 gene mutation.Therefore,the clinical data of family members were collected and investigated.A total of four members of the family were found to have heterozygous mutations in the KLF11 gene c.G31A,which resulted in a change in the corresponding amino acid p.D11N.Three patients had diabetes mellitus,and one patient had impaired glucose tolerance.CONCLUSION The heterozygous mutation of the KLF11 gene c.G31A(p.D11N)is a new mutation site of MODY7.Subsequently,the main treatment included dietary interventions and oral drugs.展开更多
文摘KLF11是Kruppel样转录因子家族中的成员,在胰腺、肌肉、肝脏等多种组织中广泛表达,参与调控细胞增殖、糖脂代谢等多种重要的生理及病理过程。研究表明,KLF11在胰腺癌、肺癌等多种肿瘤中的表达量明显下降,其抑癌作用亦明显降低,这种异常表达参与了肿瘤的发生发展过程。人群及动物模型研究发现,KLF11能够调控胰岛素基因的表达,与青少年发病型成年糖尿病(maturity onset diabetes in young,MODY)密切相关。此外,KLF11还调控脂质氧化与转运,并参与白色脂肪的棕色化过程。本文就其生物学功能研究进展作一综述。
文摘BACKGROUND Maturity-onset diabetes of the young(MODY)is the most common monogenic type of diabetes.Recently,14 gene mutations have been found to be associated with MODY.In addition,the KLF11 gene mutation is the pathogenic gene of MODY7.To date,the clinical and functional characteristics of the novel KLF11mutation c.G31A have not yet been reported.CASE SUMMARY We report of a 30-year-old male patient with a one-year history of nonketosisprone diabetes and a 3-generation family history of diabetes.The patient was found to carry a KLF11 gene mutation.Therefore,the clinical data of family members were collected and investigated.A total of four members of the family were found to have heterozygous mutations in the KLF11 gene c.G31A,which resulted in a change in the corresponding amino acid p.D11N.Three patients had diabetes mellitus,and one patient had impaired glucose tolerance.CONCLUSION The heterozygous mutation of the KLF11 gene c.G31A(p.D11N)is a new mutation site of MODY7.Subsequently,the main treatment included dietary interventions and oral drugs.
